reference/6412519

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6412519

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1213
issn	1476-5462 0969-7128
issueIdentifier	18
pageRange	1207-1213
publicationName	Gene Therapy
startingPage	1207
bibliographicCitation	Xiao F, Wei Y, Yang L, Zhao X, Tian L, Ding Z, Yuan S, Lou Y, Liu F, Wen Y, Li J, Deng H, Kang B, Mao Y, Lei S, He Q, Su J, Lu Y, Niu T, Hou J, Huang MJ. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin. Gene Ther. 2002 Sep;9(18):1207–13. doi: 10.1038/sj.gt.3301788. PMID: 12215887.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa2ba5b6d7c4900f5d4e5ea26c00ffb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a894d7acfde8445f77a8ffa35dc530aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a30d6205902a92635933d19f12c66595 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c41f6793f141cf55b59510e7d2799b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b888110280df018e13ec022609cc409 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d949f41a978d14a206285f41e078af31 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d95344cd43ae14787e74118f921db55f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1254f51de8371a063fb49149571ffaa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16e3229c5176bd89a9c1fa6f00ad094a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5feed4d7b4be1a0a824eed28a42862b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32a3bb062a226b0a921c434ab0dc5253 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_785788f5105a72901bebbd2697b3f3cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06c4281e447dbd1a31dbdec43bd86592 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57df1fa1de77178e7fb676e1eb23ccc3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cbe346de8561c61b999d45f3409ae3b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12f4f833d46e5039db17e67c5f49d173 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33238294c218f5e95757ae3df6f86d86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46733b06818b9f7fe2a46a04ccb26968 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_611ae8823210c571f4a38af009dc8dfd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_746953fe67c5ff7970c943b3bc2167dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83003a06ecddcb00b42750df93639170
date	2002-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12215887 https://doi.org/10.1038/sj.gt.3301788
isPartOf	https://portal.issn.org/resource/ISSN/1476-5462 https://portal.issn.org/resource/ISSN/0969-7128 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8603
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin
discusses	http://id.nlm.nih.gov/mesh/M0016224 http://id.nlm.nih.gov/mesh/M0172278 http://id.nlm.nih.gov/mesh/M0003193 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0337576 http://id.nlm.nih.gov/mesh/M0019071
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab37329db9eafe41915fd02e8a5d3d07 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7ca0e8b95b90daa8381b317fe50ccc9c

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64202

Total number of triples: 54.